Current gold standard lower extremity cutaneous wound management is not always effective. Cutaneous wounds generate a "current of injury" which is directly involved in wound healing processes. Application of exogenous electrical stimulation has been hypothesised to imitate the natural electric current that occurs in cutaneous wounds.
1,2
Chronic wounds are divided aetiologically into arterial insufficiency, venous insufficiency, diabetes and pressure-related wounds.
3 Chronic lower extremity wounds represent a significant burden on patients' quality of life and the healthcare system. 4, 5 Although there are standard treatment modalities available for the management of lower extremity wounds based on aetiology including revascularisation, 6 compression therapy, 7 offloading 8-11 and pressure relief, 12 they are not always effective. Adjuvant therapies are also available but their optimal use is unknown. [13] [14] [15] Human skin is electrically charged, termed the "skin battery".
16
Cutaneous wounds generate large and persistent endogenous electric currents and fields named the "current of injury" 16, 17 ( Figure 1a ) which is involved in numerous processes of wound healing. 4 These observations have led to the hypothesis that applied electrical stimulation (ES) may promote chronic wound healing by imitating the natural electrical current that occurs in cutaneous wounds.
18
ES affects all the stages of wound healing, and its mechanism of action is multifactorial as identified by preclinical studies which have led to its implementation in the management of human wounds ( Figure 1a and Data S1).
18-27
Several different waveforms and delivery methods of ES have been used in chronic lower extremity wound healing ( Figure 2 ). The wide variations in ES protocols used have left uncertainty as to which ES waveform is superior in the management of cutaneous wounds. The aim of this comprehensive review was to provide a detailed update on the different ES modalities used in the management of chronic lower extremity wounds.
| SEARCH STRATEGY
Please refer to Data S1 and Figure 3 . 
| PULSED CURRENT
Pulsed Current is the unidirectional or bidirectional flow of charged particles for less than one-second in which each pulse is separated by a longer off period of no current flow. 29 It is usually delivered with both polarity electrodes placed on the wound or proximally on the skin. Pulsed current can have a monophasic or biphasic waveform.
Monophasic pulsed current can be described as high voltage pulsed current (HVPC) or low voltage pulsed current (LVPC) with the treatment electrode usually placed on the wound surface. 30 The biphasic pulsed current waveform can be asymmetric or symmetric with both electrodes usually being placed on the wound edge. 31 There are multiple methods of assessing pulsed current studies. We have separated studies based on wound type treated (Table S1) ; however, other beneficial techniques include separating monophasic and biphasic pulsed current as undertaken in a meta-analysis by Koel and Houghton.
32
Two studies have assessed the effect of HVPC on arterial insufficiency lower extremity wound healing. A retrospective observational study showed periwound transcutaneous oxygen (TcPo2) increased during electrotherapy, and at 1 year 90% of electrically stimulated wounds had healed in comparison to only 29% with standard care.
33
However, numbers recruited over the 4-year period were relatively low at 11 patients in each group. These results were further corroborated with a randomised controlled trial (RCT) comparing active HVPC against the application of sham HVPC over 14 weeks in eight patients with ischaemic lower extremity wounds. 34 The use of active HVPC led to smaller wounds and improved periwound microcirculation as assessed by TcPo2 measurements. Although treatment duration was long as with the first study, participant numbers were small increasing the likelihood of possible false-positive results. Debreceni et al.
showed an 83% improvement in a prospective study of 24 patients with chronic lower extremity ischaemic wounds, 75% of whom had tissue loss prior to commencing biphasic pulsed current. They noted wound healing and cessation of gangrenous processes following ES.
They also found a significant improvement in pain-free walking distance and increases in distal tissue oxygen saturations. analysis. This is in keeping with an earlier RCT which found similar wound healing rates in patients who were managed with ES or standard treatment postsurgery. 39 The findings from the two studies suggest that HVPC does not enhance wound healing in comparison with successful surgery and however is superior to conservative management. Unfortunately, although the three studies by Franek et al.
37-39
included large numbers of patients with a relatively long duration of treatment, they all lacked blinding. In contrast, a large RCT of 305 subjects divided into nine different treatment groups found compression therapy as an adjunctive treatment to causal surgical intervention was superior to ES in terms of wound healing and that ES was no more effective than compression therapy in those managed conservatively.
40
Although randomised, there was no blinding to intervention and the initial decision of grouping was based on patient choice as to whether they agreed to surgical intervention or not and the groups were not equally distributed. A double-blinded RCT showed no significant difference in venous lower extremity wound area, capillary density and TcPo2 between subjects receiving LVPC or standard compression F I G U R E 2 (a) Electrical stimulation modalities used in the treatment of lower extremity cutaneous wounds with their associated range of parameters. (b) Waveforms of the different electrical stimulation modalities used in the management of lower extremity cutaneous wounds; i) high voltage pulsed current; ii) symmetric biphasic pulsed current; iii) asymmetric biphasic pulsed current. FREMS, frequency rhythmic electrical modulation systems; LF-SNS, low-frequency transcutaneous sensory nerve stimulation; DC, direct current; LIDC, low-intensity direct current; WMCS, wireless microcurrent stimulation; V, volts; Hz, hertz; A, ampere; AC, alternating current F I G U R E 3 Flow chart of search strategy and results therapy. 41 However, in the ES group, wound area reduced from a median of 550-80 mm 2 , a more than twofold decrease in comparison with the placebo group. This lack of significance was also found in a prospective study with small subject numbers which found no signif- and topical treatments.
53
Six studies assessed the effect of pulsed current on a combination of lower extremity wounds of various aetiologies. Houghton et al.
showed application of HVPC with no polarity switch during treatment, for a short duration of only four weeks at 100 μs, at a frequency of 100 Hz and 150 V for 45 minutes, 3 times weekly, reduced the wound size of arterial, venous and diabetic lower extremity wounds by almost 50% which was more than twice the amount compared to sham treatment. 54 This was supported by a case series of three patients with mixed aetiology lower extremity wounds. 55 A further case series of 10 patients with conventional treatment resistant leg wounds of various aetiologies responded to complete healing within an average time of 17.6 weeks. 56 However, HVPC treatment was given in conjunction with acoustic pressure wound therapy and also the concomitant wound dressings and therapies given varied between patients.
A RCT assessing pulsed current in lower extremity wound healing found accelerated healing of amputation stumps in patients who had undergone a major lower extremity amputation secondary to arterial or diabetic causes. 57 The authors, however, declare the randomisation process was not perfect, and indeed, ES did not affect re-amputation rates. In two prospective studies, Kaada first showed a 90% healing rate in 10 patients who underwent high-frequency pulsed current ES for lower extremity wounds of various aetiologies 58 and in a second study found low-frequency pulsed current accelerated healing in patients with chronic lower extremity leprous wounds via a proposed mechanism of microcirculation improvements secondary to ES treatment.
59
The consensus from the above studies is the use of pulsed current is overall beneficial in the management of venous and diabetic lower extremity wounds. Pulsed current treatment is not superior to causal surgical intervention but is beneficial compared to standard wound care in the majority of cases. There is a lack of high-quality studies available to judge confidently its effect on arterial and pressure wounds, and further robust trials are necessary to identify the optimal pulsed current waveform.
| DIRECT CURRENT
DC is the continuous, unidirectional flow of charged particles for 1 second or longer. 29 Application of DC can lead to wound irritation and damage. 29 Therefore, in wound studies, application of low-intensity direct current (LIDC) is utilised (Table S2) . LIDC is a continuous monophasic waveform with current of an intensity less than or equal to 1 mA. LIDC is often subdivided into LIDC and microcurrent. The difference is the latter produces only subsensory-level stimulation.
60
Only subanalysis of a single prospective study has demonstrated the effect of DC on ischaemic lower extremity wounds. 
67
The seven studies investigating the effects of DC on lower extremity wounds provide limited information. Overall the higher grade studies assessing the effect of DC on lower extremity wounds of venous aetiology show no benefit; however, the studies only include small number of participants or the active intervention is confounded by other concomitant treatments. As with venous wound, high-grade studies show no benefit of DC on diabetic lower extremity wound healing, whereas lower grade studies show a positive effect. There is only a single low-grade study showing the beneficial effects of DC on arterial insufficiency wounds, and there are no studies available assessing the effect of DC on pressure-induced lower extremity wounds.
No firm conclusions can be drawn on the effect of DC on various lower extremity wound aetiologies, and further robust research is needed to firmly establish any benefits.
| FREQUENCY RHYTHMIC ELECTRICAL MODULATION SYSTEMS
FREMS is a biocompatible device that uses sequences of electrical stimuli that automatically vary in terms of duration, pulse, frequency and voltage amplitude which is led by the patient. This in turn produces improvement in skin microvascular circulation and is the basis for its use in wound healing 68 (Table S3) .
Three RCTs to date have assessed the effect of FREMS on lower extremity wound healing. All unfortunately did not clarify if either the participant or investigator was blinded. Santamato et al. applied either antiseptic topical alone or in combination with FREMS to venous leg wounds for 3 weeks. They found FREMS led to a decrease in wound surface area by 90% at 30 days from treatment cessation which was significantly superior to that seen in the control arm.
69
Jankovic and Binic used FREMS in a randomised control trial in 35 patients with chronic lower extremity wounds of various aetiologies.
They found FREMS accelerated wound healing (82% reduction in leg wound surface in the treatment group compared to a 46% reduction in the control group) and significantly reduced pain. 70 However, a standardised dressing protocol was not used in the study. A more recent randomised control trial using FREMS identified accelerated wound healing of lower extremity wounds in the active treatment group; however, by the end of the study, the percentage of wounds healed in the two groups were similar (90%). 71 A weaker case-control study in 30 patients with diabetic foot wounds found application of FREMS led to a significant improvement in wound healing at 30 and 45 days postcommencement of treatment compared to traditional treatment. 72 The lack of clarification as to the standard wound therapy used in the studies to date and the absence of its effect on arterial and pressure-related wounds make the need for more robust clinical trials to be conducted to further clarify the effect of FREMS on lower extremity wound healing.
| LOW-FREQUENCY TRANSCUTANEOUS SENSORY NERVE STIMULATION
LF-SNS has been shown to improve wound healing in animals and induce vasodilatation through activation of sensory nerve terminals
73
( Table S3 ). The LF-SNS is a battery-operated device that delivers low-frequency ES with intensity of 4 mA and frequency of 5 Hz. 74 The application of the device involves electrodes which are strapped over a proximal nerve innervating the wound. 74 Please refer to Data S1 for further information regarding studies.
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| BIOELECTRICAL STIMULATION
The use of only two bioelectric dressings employed to deliver ES to lower extremity wounds has been reported (Table S3) with the use of PosiFect RD® within 12 weeks. 76, 77 Procellera® is also a battery-operated single layer dressing that is activated by wound moisture to deliver ES to the wound site. 29 The use of Procellera® has shown faster healing, improved scarring and patient subjective outcomes in lower extremity acute cutaneous wounds.
78
However, this was a relatively small case series of 13 patients and did not include chronic wounds. Well-designed RCTs are necessary including the effect of these bioelectric dressings on chronic lower extremity wounds before firm conclusions on the clinical benefits can be drawn.
| CONCLUSIONS AND FUTURE PERSPECTIVES
The majority of studies support the beneficial effects of pulsed current over conservative management of lower extremity cutaneous wounds. Although it appears to have no benefit over causal surgical intervention, it is a treatment option which could be utilised in those patients unsuitable for surgery. DC seems inferior to pulsed current, and although the other waveforms and modalities appear promising, they still lack large trial data to recommend a firm conclusion with regard to their use in lower extremity cutaneous wound healing.
The ideal ES device needs to be non-invasive, portable and costeffective and provides minimal interference with patients' daily life. LF-SNS lacks large trial data, and the single RCT to date provides conflicting findings compared to earlier reports. A portable electrobiofeedback device which was first investigated on its successful effects on cutaneous scarring 80, 81 has shown accelerated healing of acute cutaneous wounds in the arm. 22, 27, 82, 83 It produces a novel electrical waveform which degenerates with time termed the degenerate wave. It is a low-intensity device with a concentric electrode, which applies impulses of short duration (a six-hundredth of a second) and of relatively high amplitude (20-80 V) with a frequency default at 60 Hz and detects changes in skin impedance. 30 However to date, the effects of this device have not been investigated in lower extremity cutaneous wounds.
On balance, the majority of studies have shown accelerated wound healing with the use of ES compared to standard therapy and placebo. There are several ES modalities available and used successfully for lower extremity wound healing; however, the number of studies ranges in quantity and quality across the different modal- 
